Cargando…
A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma
BACKGROUND: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part II of the survey, the aim of this study is to evaluate the national patterns of clinical practice fo...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221470/ https://www.ncbi.nlm.nih.gov/pubmed/32390349 http://dx.doi.org/10.14791/btrt.2020.8.e6 |
_version_ | 1783533373212327936 |
---|---|
author | Kim, Sung Kwon Yoon, Hong In Yoon, Wan-Soo Cho, Jin Mo Moon, Jangsup Kim, Kyung Hwan Kim, Se Hoon Kim, Young Il Kim, Young Zoon Kim, Ho Sung Dho, Yun-Sik Park, Jae-Sung Park, Ji Eun Seo, Youngbeom Sung, Kyoung Su Song, Jin Ho Wee, Chan Woo Lee, Se-Hoon Lim, Do Hoon Im, Jung Ho Chang, Jong Hee Han, Myung-Hoon Hong, Je Beom Hwang, Kihwan Park, Chul-Kee Lee, Youn Soo Gwak, Ho-Shin |
author_facet | Kim, Sung Kwon Yoon, Hong In Yoon, Wan-Soo Cho, Jin Mo Moon, Jangsup Kim, Kyung Hwan Kim, Se Hoon Kim, Young Il Kim, Young Zoon Kim, Ho Sung Dho, Yun-Sik Park, Jae-Sung Park, Ji Eun Seo, Youngbeom Sung, Kyoung Su Song, Jin Ho Wee, Chan Woo Lee, Se-Hoon Lim, Do Hoon Im, Jung Ho Chang, Jong Hee Han, Myung-Hoon Hong, Je Beom Hwang, Kihwan Park, Chul-Kee Lee, Youn Soo Gwak, Ho-Shin |
author_sort | Kim, Sung Kwon |
collection | PubMed |
description | BACKGROUND: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part II of the survey, the aim of this study is to evaluate the national patterns of clinical practice for patients with diffuse midline glioma and meningioma. METHODS: A web-based survey was sent to all members of the KSNO by email. The survey included 4 questions of diffuse midline glioma and 6 questions of meningioma (including 2 case scenarios). All questions were developed by consensus of the Guideline Working Group. RESULTS: In the survey about diffuse midline glioma, 76% respondents performed histologic confirmation to identify H3K27M mutation on immunohistochemical staining or sequencing methods. For treatment of diffuse midline glioma, respondents preferred concurrent chemoradiotherapy with temozolomide (TMZ) and adjuvant TMZ (63.8%) than radiotherapy alone (34.0%). In the survey about meningioma, respondents prefer wait-and-see policy for the asymptomatic small meningioma without peritumoral edema. However, a greater number of respondents had chosen surgical resection as the first choice for all large size meningiomas without exception, and small size meningiomas with either peritumoral edema or eloquent location. There was no single opinion with major consensus on long-term follow-up plans for asymptomatic meningioma with observation policy. As many as 68.1% of respondents answered that they would not add any adjuvant therapies for World Health Organization grade II meningiomas if the tumor was totally resected including dura. CONCLUSION: The survey demonstrates the prevailing clinical practice patterns for patients with diffuse midline glioma and meningioma among members of the KSNO. This information provides a point of reference for establishing a practical guideline in the management of diffuse midline glioma and meningioma. |
format | Online Article Text |
id | pubmed-7221470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-72214702020-05-24 A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma Kim, Sung Kwon Yoon, Hong In Yoon, Wan-Soo Cho, Jin Mo Moon, Jangsup Kim, Kyung Hwan Kim, Se Hoon Kim, Young Il Kim, Young Zoon Kim, Ho Sung Dho, Yun-Sik Park, Jae-Sung Park, Ji Eun Seo, Youngbeom Sung, Kyoung Su Song, Jin Ho Wee, Chan Woo Lee, Se-Hoon Lim, Do Hoon Im, Jung Ho Chang, Jong Hee Han, Myung-Hoon Hong, Je Beom Hwang, Kihwan Park, Chul-Kee Lee, Youn Soo Gwak, Ho-Shin Brain Tumor Res Treat Original Article BACKGROUND: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part II of the survey, the aim of this study is to evaluate the national patterns of clinical practice for patients with diffuse midline glioma and meningioma. METHODS: A web-based survey was sent to all members of the KSNO by email. The survey included 4 questions of diffuse midline glioma and 6 questions of meningioma (including 2 case scenarios). All questions were developed by consensus of the Guideline Working Group. RESULTS: In the survey about diffuse midline glioma, 76% respondents performed histologic confirmation to identify H3K27M mutation on immunohistochemical staining or sequencing methods. For treatment of diffuse midline glioma, respondents preferred concurrent chemoradiotherapy with temozolomide (TMZ) and adjuvant TMZ (63.8%) than radiotherapy alone (34.0%). In the survey about meningioma, respondents prefer wait-and-see policy for the asymptomatic small meningioma without peritumoral edema. However, a greater number of respondents had chosen surgical resection as the first choice for all large size meningiomas without exception, and small size meningiomas with either peritumoral edema or eloquent location. There was no single opinion with major consensus on long-term follow-up plans for asymptomatic meningioma with observation policy. As many as 68.1% of respondents answered that they would not add any adjuvant therapies for World Health Organization grade II meningiomas if the tumor was totally resected including dura. CONCLUSION: The survey demonstrates the prevailing clinical practice patterns for patients with diffuse midline glioma and meningioma among members of the KSNO. This information provides a point of reference for establishing a practical guideline in the management of diffuse midline glioma and meningioma. The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2020-04 2020-04-30 /pmc/articles/PMC7221470/ /pubmed/32390349 http://dx.doi.org/10.14791/btrt.2020.8.e6 Text en Copyright © 2020 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Sung Kwon Yoon, Hong In Yoon, Wan-Soo Cho, Jin Mo Moon, Jangsup Kim, Kyung Hwan Kim, Se Hoon Kim, Young Il Kim, Young Zoon Kim, Ho Sung Dho, Yun-Sik Park, Jae-Sung Park, Ji Eun Seo, Youngbeom Sung, Kyoung Su Song, Jin Ho Wee, Chan Woo Lee, Se-Hoon Lim, Do Hoon Im, Jung Ho Chang, Jong Hee Han, Myung-Hoon Hong, Je Beom Hwang, Kihwan Park, Chul-Kee Lee, Youn Soo Gwak, Ho-Shin A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma |
title | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma |
title_full | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma |
title_fullStr | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma |
title_full_unstemmed | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma |
title_short | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma |
title_sort | national consensus survey for current practice in brain tumor management ii: diffuse midline glioma and meningioma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221470/ https://www.ncbi.nlm.nih.gov/pubmed/32390349 http://dx.doi.org/10.14791/btrt.2020.8.e6 |
work_keys_str_mv | AT kimsungkwon anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT yoonhongin anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT yoonwansoo anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT chojinmo anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT moonjangsup anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimkyunghwan anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimsehoon anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimyoungil anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimyoungzoon anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimhosung anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT dhoyunsik anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT parkjaesung anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT parkjieun anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT seoyoungbeom anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT sungkyoungsu anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT songjinho anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT weechanwoo anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT leesehoon anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT limdohoon anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT imjungho anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT changjonghee anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT hanmyunghoon anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT hongjebeom anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT hwangkihwan anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT parkchulkee anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT leeyounsoo anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT gwakhoshin anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT anationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimsungkwon nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT yoonhongin nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT yoonwansoo nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT chojinmo nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT moonjangsup nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimkyunghwan nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimsehoon nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimyoungil nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimyoungzoon nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT kimhosung nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT dhoyunsik nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT parkjaesung nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT parkjieun nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT seoyoungbeom nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT sungkyoungsu nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT songjinho nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT weechanwoo nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT leesehoon nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT limdohoon nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT imjungho nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT changjonghee nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT hanmyunghoon nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT hongjebeom nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT hwangkihwan nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT parkchulkee nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT leeyounsoo nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT gwakhoshin nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma AT nationalconsensussurveyforcurrentpracticeinbraintumormanagementiidiffusemidlinegliomaandmeningioma |